Logo of the Belgian government
 

Study 2014-05-02 (HSR) Quality indicators for ovarian cancer

Planned study - Ovarian cancer is the second most frequent gynaecological tumour in Belgium. Annually almost 900 women are diagnosed and treated for this disease. Treatment is based on the combination of radical surgery and medication (chemotherapy, targeted therapy). Due to complexity of its treatment, a variation in the quality of care and survival is suspected. The purpose of this project is to evaluate the quality of care for ovarian cancer on the basis of a set of indicators, and to describe the variability in processes of care and in outcomes per hospital. The indicators will be calculated using the data from the cancer registry, linked to administrative claims data. This approach has already been successfully applied in previous KCE projects for the following cancers: breast, testis, oesophageal and stomach.

published on 26-03-2014